investorscraft@gmail.com

Stock Analysis & ValuationKimball Electronics, Inc. (KE)

Previous Close
$30.21
Sector Valuation Confidence Level
Moderate
Valuation methodValue, $Upside, %
Artificial intelligence (AI)36.5421
Intrinsic value (DCF)11.96-60
Graham-Dodd Method26.17-13
Graham Formulan/a

Strategic Investment Analysis

Company Overview

Kimball Electronics, Inc. (NASDAQ: KE) is a leading contract electronics manufacturing services (EMS) provider specializing in diversified manufacturing solutions for the automotive, medical, industrial, and public safety sectors. Founded in 1961 and headquartered in Jasper, Indiana, the company offers end-to-end services, including design support, supply chain management, rapid prototyping, and product lifecycle management. With a global footprint spanning the U.S., China, Mexico, Poland, Romania, Thailand, and Vietnam, Kimball Electronics leverages its expertise in printed circuit board assemblies, medical device manufacturing, and automation to serve a broad client base. The company’s focus on industrialization, reliability testing, and precision engineering positions it as a trusted partner in high-growth industries. As part of the industrials sector, Kimball Electronics plays a critical role in enabling innovation across healthcare, automotive electrification, and industrial automation, making it a key player in the EMS industry.

Investment Summary

Kimball Electronics presents a mixed investment profile. On the positive side, the company operates in high-growth end markets like automotive and medical devices, supported by a diversified global manufacturing footprint. Its revenue of $1.71B and positive net income of $20.5M in the latest fiscal year reflect stable demand. However, the company’s thin margins (EPS of $0.81) and lack of dividend payments may deter income-focused investors. Additionally, its beta of 1.112 suggests higher volatility compared to the broader market. While its strong operating cash flow ($73.2M) and manageable debt ($294.8M) provide financial flexibility, investors should weigh its exposure to supply chain risks and competitive pressures in the EMS industry.

Competitive Analysis

Kimball Electronics competes in the highly fragmented EMS industry, where differentiation hinges on technical expertise, global scalability, and cost efficiency. The company’s competitive advantage lies in its diversified end-market exposure, particularly in automotive and medical devices, which are less cyclical than consumer electronics. Its vertically integrated services—from design to production—allow for deeper customer engagement and higher-value contracts. However, Kimball faces intense competition from larger EMS providers like Flex and Jabil, which benefit from greater economies of scale and broader geographic reach. While Kimball’s focus on niche markets (e.g., medical disposables, industrial automation) helps mitigate direct competition, its smaller size limits its ability to compete on pricing for high-volume contracts. The company’s strategic investments in automation and Southeast Asian operations (Thailand, Vietnam) enhance cost competitiveness, but reliance on outsourced manufacturing in China and Mexico exposes it to geopolitical and tariff risks. Overall, Kimball’s positioning as a mid-tier EMS player with specialized capabilities offers stability but may constrain rapid growth in a capital-intensive industry.

Major Competitors

  • Flex Ltd. (FLEX): Flex is a global EMS leader with a broader product portfolio and larger scale ($26B revenue), enabling lower production costs. It excels in high-margin segments like cloud infrastructure and automotive but faces margin pressure from commoditized electronics. Compared to Kimball, Flex’s size provides supply chain advantages but reduces agility in niche markets.
  • Jabil Inc. (JBL): Jabil’s $34B revenue and diversified client base (including Apple) give it significant pricing power. It leads in advanced packaging and 5G infrastructure but is more exposed to consumer electronics volatility. Kimball’s focus on medical and industrial markets offers more stable demand compared to Jabil’s cyclical exposure.
  • Sanmina Corporation (SANM): Sanmina specializes in complex manufacturing for aerospace and healthcare, overlapping with Kimball’s medical segment. Its $7.4B revenue and strong engineering capabilities make it a formidable competitor, though Kimball’s smaller size allows for more tailored customer solutions in mid-volume production.
  • Plexus Corp. (PLXS): Plexus focuses on low-volume, high-mix production for regulated industries, similar to Kimball. Its $4.2B revenue and strong medical/life sciences presence create direct competition, but Kimball’s automotive segment provides additional diversification.
HomeMenuAccount